CN103054981B - External traditional Chinese medicine for treating abdominal malignant tumours - Google Patents
External traditional Chinese medicine for treating abdominal malignant tumours Download PDFInfo
- Publication number
- CN103054981B CN103054981B CN201310036743.XA CN201310036743A CN103054981B CN 103054981 B CN103054981 B CN 103054981B CN 201310036743 A CN201310036743 A CN 201310036743A CN 103054981 B CN103054981 B CN 103054981B
- Authority
- CN
- China
- Prior art keywords
- parts
- prepared
- chinese medicine
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an external traditional Chinese medicine for treating abdominal malignant tumours, which is prepared from the following medicinal materials in parts by weight: 10 parts of rhizoma corydalis, 21 parts of prepared semen strychni, 9 parts of asarum, 25 parts of Oldenlandia diffusa, 10 parts of Scutellaria baicalensis, 10 parts of elecampane, 10 parts of radix angelicae, 15 parts of the root of three-nerved spicebush, 10 parts of scorpio, 9 parts of borneol, 16 parts of prepared radix aconiti agrestis, 10 parts of wall gecko, 7 parts of centipede, 10 parts of prepared frankincense, 10 parts of prepared myrrh, 16 parts of Sculellaria barbata, 10 parts of prepared monkshood, and 15 parts of Chinese actinidia root. Clinical experiments prove that the external traditional Chinese medicine disclosed by the invention is capable of treating abdominal malignant tumours safely and effectively.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of external application Chinese medicine for the treatment of abdominal cavity malignant tumor.
Background technology
Tumor (Tumor) be body under various carcinogenic factor effects, some cells of local organization lose the normal regulation to its growth on gene level, cause its clonal abnormality hypertrophy and the abnormality that forms, have optimum and pernicious minute.As the term suggests abdominal cavity malignant tumor is long in Intraabdominal malignant tumor.
For the treatment of abdominal cavity malignant tumor, mainly take at present operation and chemicotherapy as main, but curative effect is also undesirable, still lacks the effective medicine of generally recognized as safe.
Summary of the invention
The present invention aims to provide a kind of external application Chinese medicine for the treatment of abdominal cavity malignant tumor, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing abdominal cavity malignant tumor.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of external application Chinese medicine for the treatment of abdominal cavity malignant tumor, it is characterized in that, by the medical material of following weight proportion, be prepared from: 10 parts of Rhizoma Corydalis, 21 parts of Semen Strychni (processed)s, 9 parts of Herba Asaris, 25 parts of Herba Hedyotidis Diffusaes, 10 parts of Radix Scutellariaes, 10 parts of the Radix Aucklandiae, 10 parts of the Radixs Angelicae Dahuricae, 15 parts of the Radixs Linderae, 10 parts of Scorpios, 9 parts of Borneolum Syntheticums, 16 parts of Radix Aconiti Kusnezoffii Preparatas, 10 parts of Gekko Swinhonis, 7 parts of Scolopendras, 10 parts of Olibanum (processed)s, 10 parts of Myrrha (processed)s, 16 parts of Herba Scutellariae Barbataes, 10 parts of Radix Aconiti Preparatas, 15 parts of Radix Actinidiae Chinensis.
Below in conjunction with tcm theory, beneficial effect of the present invention is described:
Semen Strychni (processed), Radix Aconiti Preparata, Radix Aconiti Kusnezoffii Preparata, Olibanum (processed), are all key medicines of pain relieving eliminating stagnation, mutual compatibility, the complementary multiplication of drug effect.Herba Hedyotidis Diffusae: return lung, liver, stomach warp, clearing away heat-damp and promoting diuresis, the cold unlikely stomach that hinders of the property of medicine, the anti-merit that has removing food stagnancy food.Herba Asari acrid in the mouth perfume (or spice) is altered. and can outer dispersing wind and cold. again can internalization cold fluid-retention, the pain relieving of having one's ideas straightened out; A most important effect can enter exactly the moon and search heresy, and wind and cold, phlegm retention search is separated and appear external.Rhizoma Corydalis is mainly used in all pain cards of stagnation of QI and blood, and pungent loose temperature is logical, " stagnation of QI in energy promoting the circulation of blood, stasis in gas, therefore specially control upper and lower all pains all over the body ".Radix Scutellariae heat clearing and damp drying, eliminating fire and detoxication; Scorpio relieving spasm by subduing liver-wind, detoxicating and resolving stagnation of pathogens; Radix Aucklandiae circulation of qi promoting, in tune, pain relieving, can rise and can fall.Radix Angelicae Dahuricae cold expelling is sensible, wind-expelling pain-stopping, detumescence and apocenosis; Radix Linderae promoting the circulation of QI to relieve pain, warming kidney for dispelling cold.The Borneolum Syntheticum refreshment of having one's ideas straightened out, clearing away heat to alleviate pain.Gekko Swinhonis is salty, cold, slightly poisonous, removing obstruction for relieving pain, expelling wind for relieving convulsion.Scolopendra endogenous wind stopping spasmolytic, merit poison eliminating stagnation, removing obstruction in the collateral to relieve pain; Herba Scutellariae Barbatae: heat-clearing and toxic substances removing, blood stasis dispelling diuresis.All medicines all have different returning through, the different five tastes above, and compatibility really brings out the best in each other, and plays altogether eliminating stagnationization and becomes silted up, the merit of alleviating pain and detumescence de-swelling.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
Inventor collects 150 routine abdominal cavity malignant tumor (as: transfer of oophoroma abdominal cavity, advanced liver cancer, advanced colorectal cancer, late gastric cancer, advanced pancreatic cancer) patients in October, 2009-2011 altogether between year March.Age 42-65 year, course of disease 0.5-6.Be divided at random: treatment group 100 examples, blank group 50 examples.The data there was no significant differences such as two groups of ages, the state of an illness, have comparability.
2, test method
The unguentum that 2.1 treatment group external application the present invention make according to specific embodiment 1, external application every day once, maintains more than 16 hours at every turn.One month course for the treatment of.
2.2 blank group external application placebo, external application every day once, maintains more than 16 hours at every turn.One month course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, test chamber inspection tumor is obviously dwindled or disappears.Take a turn for the better: clinical symptom relief, lab testing tumor is dwindled or reached zero growth, and the state of an illness is controlled.Invalid: clinical symptoms is without being clearly better, and tumor continues to increase.
3.2 treatment statistical results are in Table 1.
Table 1 liang group curative effect comparison
| Group | n | Recovery from illness | Take a turn for the better | Invalid | Total effective rate (%) | Untoward reaction example |
| Treatment group | 100 | 5（5%） | 88（88%) | 7(7%) | 93% | 3 |
| Blank group | 50 | 0（0%） | 5（10%） | 45（90%） | 10% | 0 |
Visible, the medicine that the present invention makes can safe and effectively be controlled abdominal cavity malignant tumor.
The specific embodiment
In order to understand better and to implement the present invention, below in conjunction with specific embodiment, further illustrate the present invention.
specific embodiment 1
Take: 10 grams of Rhizoma Corydalis, 21 grams of Semen Strychni (processed)s, 9 grams of Herba Asaris, 25 grams of Herba Hedyotidis Diffusaes, 10 grams of Radix Scutellariaes, 10 grams of the Radix Aucklandiae, 10 grams of the Radixs Angelicae Dahuricae, 15 grams of the Radixs Linderae, 10 grams of Scorpios, 9 grams of Borneolum Syntheticums, 16 grams of Radix Aconiti Kusnezoffii Preparatas, 10 grams of Gekko Swinhonis, 7 grams of Scolopendras, 10 grams of Olibanum (processed)s, 10 grams of Myrrha (processed)s, 16 grams of Herba Scutellariae Barbataes, 10 grams of Radix Aconiti Preparatas, 15 grams of Radix Actinidiae Chinensis.
Last appropriate vinegar and the Mel of adding of levigation reconciles into cream altogether, must meet the unguentum of one day consumption of normal adult.Be used for the treatment of abdominal cavity malignant tumor, spread on belly place outward, for the purpose of taking action conveniently, available gauze is wound around and wraps, and once a day, maintains more than 16 hours at every turn.
This prescription toxicity is larger, can only be for external application, by skin, absorb, reach tumor suppression dispersing tumor eliminating stagnation with the object of pain relieving, can not be oral, clinically for the transfer of oophoroma abdominal cavity, advanced liver cancer, advanced colorectal cancer, late gastric cancer, advanced pancreatic cancer etc., ease the pain, and alleviate abdominal distention, improve clinical symptoms, improving life quality all has good curative effect, and couple of days fast after patient's external just can be seen clinical effectiveness, the in the situation that of skin of abdomen conditions permit, can be interrupted application half a year, try to be subject to during clinical patient's extensive approval.
Claims (1)
1. an external application Chinese medicine for the treatment of abdominal cavity malignant tumor, it is characterized in that, by the medical material of following weight proportion, be prepared from: 10 parts of Rhizoma Corydalis, 21 parts of Semen Strychni (processed)s, 9 parts of Herba Asaris, 25 parts of Herba Hedyotidis Diffusaes, 10 parts of Radix Scutellariaes, 10 parts of the Radix Aucklandiae, 10 parts of the Radixs Angelicae Dahuricae, 15 parts of the Radixs Linderae, 10 parts of Scorpios, 9 parts of Borneolum Syntheticums, 16 parts of Radix Aconiti Kusnezoffii Preparatas, 10 parts of Gekko Swinhonis, 7 parts of Scolopendras, 10 parts of Olibanum (processed)s, 10 parts of Myrrha (processed)s, 16 parts of Herba Scutellariae Barbataes, 10 parts of Radix Aconiti Preparatas, 15 parts of Radix Actinidiae Chinensis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310036743.XA CN103054981B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating abdominal malignant tumours |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310036743.XA CN103054981B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating abdominal malignant tumours |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103054981A CN103054981A (en) | 2013-04-24 |
| CN103054981B true CN103054981B (en) | 2014-02-05 |
Family
ID=48098076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310036743.XA Expired - Fee Related CN103054981B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating abdominal malignant tumours |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103054981B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943967A (en) * | 2016-06-20 | 2016-09-21 | 原巍俊 | Long-noded pit viper containing traditional Chinese medicine composition with effects of clearing dampness and resisting tumors and preparation method thereof |
| CN111110785A (en) * | 2018-11-01 | 2020-05-08 | 北京中西联盟肿瘤医学研究院(普通合伙) | Carbuncle block eliminating ointment for treating cancer pain and preparation method thereof |
| CN112386656A (en) * | 2020-12-15 | 2021-02-23 | 苏宏淼 | Tumor-eliminating pain-relieving ointment and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1108131A (en) * | 1995-01-17 | 1995-09-13 | 李勤 | Magnetic medicinal plaster for assuaging pain of person suffering from cancer |
| CN1413659A (en) * | 2002-10-17 | 2003-04-30 | 王长奎 | Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040105902A1 (en) * | 2002-12-02 | 2004-06-03 | Jiafang Chen | Compositions and methods for treating prostate cancer |
| JP2010069001A (en) * | 2008-09-18 | 2010-04-02 | Tottori Univ | Photo dynamic thermochemotherapy using photosensitive coloring agent with respect to spontaneous neoplasm of animal, and apparatus to be used thereof |
-
2013
- 2013-01-31 CN CN201310036743.XA patent/CN103054981B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1108131A (en) * | 1995-01-17 | 1995-09-13 | 李勤 | Magnetic medicinal plaster for assuaging pain of person suffering from cancer |
| CN1413659A (en) * | 2002-10-17 | 2003-04-30 | 王长奎 | Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method |
Non-Patent Citations (1)
| Title |
|---|
| 何秀兰等.癌性疼痛的治疗.《王沛肿瘤治验》.北京科学技术出版社,2012,第66-69页，尤其是第67页倒数第1行-第68页第5行. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103054981A (en) | 2013-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614422B (en) | Traditional Chinese medical decoction for treatment of acute gouty arthritis | |
| CN105477595A (en) | Traditional Chinese medicinal preparation for treating chilblain | |
| CN103054981B (en) | External traditional Chinese medicine for treating abdominal malignant tumours | |
| CN101024026A (en) | Medicine for treating parotitis | |
| CN103432269B (en) | Chinese medicinal preparation used for treating radiation enteritis | |
| CN102240302B (en) | Chinese medicine composition of super gene active peptide | |
| CN104288255A (en) | Traditional Chinese medicine preparation for treating severe acute pancreatitis | |
| CN101439149B (en) | Chinese medicinal composition for treating gastric ulcer, gastrorrhagia and gastric perforation | |
| CN104147269A (en) | Traditional Chinese medicine used for treating systemic lupus erythematosus | |
| CN103845617A (en) | Medicament for treating latent glomerulonephritis | |
| CN102671046A (en) | Chinese medicament for treating chronic appendicitis | |
| CN105687672A (en) | Traditional Chinese medicine composition for treating mastitis and mammary gland hyperplasia and preparation method thereof | |
| CN101357206A (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN103977254A (en) | Traditional Chinese medicine preparation for treating infant suppurative tonsillitis and nursing method thereof | |
| CN103933408A (en) | Traditional Chinese medicinal decoction for treating acute gouty arthritis | |
| CN102772763B (en) | Traditional Chinese medicinal composition for resisting tumor metastasis and method for preparing traditional Chinese medicinal composition | |
| CN104189158B (en) | A kind of Chinese medicinal enema of radiotherapy colitis | |
| CN103285224B (en) | Traditional Chinese medicine for treating lymphoid tuberculosis | |
| CN102973668A (en) | Compound pure traditional Chinese medicine composition for treating avian infectious laryngotracheitis and preparation method thereof | |
| CN102488804A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN103099999B (en) | Traditional Chinese medicine for treating gout disease | |
| CN103800506A (en) | Traditional Chinese medicine composition for treating infantile parotitis and preparation method thereof | |
| CN104398793A (en) | Traditional Chinese medicine composition for treating radiation pneumonitis and preparation method of traditional Chinese medicine composition | |
| CN105055665A (en) | Anti-hepatoma traditional Chinese medicine preparation | |
| CN104667201B (en) | One kind treats bronchiectasic Chinese medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140205 Termination date: 20180131 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |